Xylem Inc. $XYL Stock Holdings Increased by Strs Ohio

Strs Ohio raised its holdings in shares of Xylem Inc. (NYSE:XYL) by 107.1% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 197,819 shares of the industrial products company’s stock after buying an additional 102,304 shares during the period. Strs Ohio’s holdings in Xylem were worth $29,178,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. SJS Investment Consulting Inc. lifted its position in shares of Xylem by 1,844.4% during the 3rd quarter. SJS Investment Consulting Inc. now owns 175 shares of the industrial products company’s stock valued at $26,000 after acquiring an additional 166 shares during the last quarter. First Horizon Corp acquired a new position in shares of Xylem in the 3rd quarter worth $30,000. ST Germain D J Co. Inc. raised its position in shares of Xylem by 950.0% during the second quarter. ST Germain D J Co. Inc. now owns 252 shares of the industrial products company’s stock worth $33,000 after purchasing an additional 228 shares during the period. Grey Fox Wealth Advisors LLC purchased a new stake in shares of Xylem during the third quarter valued at $34,000. Finally, Signature Resources Capital Management LLC acquired a new position in shares of Xylem in the 2nd quarter valued at $39,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

Xylem Stock Performance

XYL stock opened at $141.06 on Friday. The firm has a 50 day simple moving average of $139.66 and a 200 day simple moving average of $141.47. Xylem Inc. has a 52 week low of $100.47 and a 52 week high of $154.27. The stock has a market cap of $34.34 billion, a P/E ratio of 36.26, a P/E/G ratio of 2.02 and a beta of 1.17. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.50 and a current ratio of 1.96.

Xylem (NYSE:XYL) last released its quarterly earnings data on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share for the quarter, beating the consensus estimate of $1.23 by $0.14. Xylem had a net margin of 10.66% and a return on equity of 10.77%. The firm had revenue of $2.27 billion for the quarter, compared to analyst estimates of $2.22 billion. During the same quarter in the prior year, the business earned $1.11 EPS. The company’s revenue for the quarter was up 7.8% compared to the same quarter last year. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. Research analysts anticipate that Xylem Inc. will post 4.65 earnings per share for the current fiscal year.

Xylem Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 23rd. Investors of record on Tuesday, November 25th were issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 1.1%. The ex-dividend date was Tuesday, November 25th. Xylem’s dividend payout ratio (DPR) is currently 41.13%.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the company. Citigroup lifted their price target on Xylem from $173.00 to $182.00 and gave the stock a “buy” rating in a research note on Wednesday, October 29th. Barclays dropped their target price on shares of Xylem from $172.00 to $166.00 and set an “overweight” rating on the stock in a research report on Wednesday, January 7th. Stifel Nicolaus upped their price target on shares of Xylem from $175.00 to $178.00 and gave the company a “buy” rating in a research report on Wednesday, October 29th. UBS Group raised their price objective on shares of Xylem from $168.00 to $175.00 and gave the stock a “buy” rating in a research note on Thursday, November 6th. Finally, Weiss Ratings reiterated a “buy (b-)” rating on shares of Xylem in a research report on Monday, December 29th. Eight investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $165.80.

Insiders Place Their Bets

In other news, EVP Claudia S. Toussaint sold 10,421 shares of the firm’s stock in a transaction dated Thursday, October 30th. The stock was sold at an average price of $152.64, for a total transaction of $1,590,661.44. Following the completion of the sale, the executive vice president directly owned 31,250 shares of the company’s stock, valued at $4,770,000. This trade represents a 25.01% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Victoria D. Harker sold 1,700 shares of Xylem stock in a transaction dated Tuesday, November 4th. The shares were sold at an average price of $148.14, for a total value of $251,838.00. Following the sale, the director owned 16,875 shares of the company’s stock, valued at approximately $2,499,862.50. This represents a 9.15% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.27% of the stock is currently owned by company insiders.

Xylem Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.